NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives
Mar 23, 2020
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast Track Designation for its lead drug candidate, its newly licensed gene therapy for diabetes, and over $26 million capital raise that will support funding of its clinical programs. “We are delighted to welcome Catherine and Michael to our executive leadership team. They join us at an exciting time as we advance our lead drug candidate into key clinical programs in non-small cell lung cancer and pursue partnership opportunities for our oncology platform and newly licensed gene therapy technology for diabetes,” Genprex CEO Rodney Varner said in the news release. “Catherine and Michael each have significant biotechnology company experience that enhances our capabilities and will be instrumental in advancing our programs. Their combined expertise in business development, corporate strategy, manufacturing, clinical trial strategy and operations and regulatory affairs will be of great value as we build Genprex into a leading gene therapy company bringing new treatment options to patients in need. We are fortunate to have raised over $26 million just prior to the current turmoil in the markets, significantly strengthening our balance sheet and well positioning us financially as we execute on our strategic plan.”
To view the full press release, visit http://nnw.fm/ZxG4j
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and other serious diseases who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), uses the company’s unique, proprietary platform which delivers cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. In January 2020, the FDA granted Fast Track Designation for Oncoprex in combination with AstraZeneca’s Tagrisso(R) for the treatment of NSCLC. For more information, please visit the company’s website at www.Genprex.com
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork.
More News
Do you have empty nest syndrome? 5 signs – and expert ways to cope
If you feel lost or overwhelmed now your children have left the nest, you are far from alone. Many parents experience empty nest syndrome at this time of the year. “Empty nest syndrome isn’t a mental health condition, but a set of feelings or symptoms that parents might feel when all their children have left home,” says Dr Elizabeth Wakeland, consultant, clinical and forensic psychologist at Cygnet Health Care in the UK. “It’s a period of significant life change where parents are trying to...
Torrential rains hit Orange County, send visitors scrambling for cover at Disneyland
A powerful, brief downpour sent Disneyland visitors scrambling for cover Friday night, closed rides and flooded parts of Frontierland as workers tried to clear backed-up drains.
I Don't Travel Without My Rescue Pup, So I Combed The Internet For These 9 Airline-Friendly Carriers
Make your travel plans with your pup a walk in the park. View Entire Post ›
Meet Tom Rhys Harries, star of DC’s body-horror Clayface
With Clayface, DC trades its usual cape-donning heroes for a chilling entry into body-horror cinema. Starring Tom Rhys Harries, the film follows Matt Hagen (played by Harries), a Hollywood star from Gotham whose run-in with a crime boss leaves his face severely disfigured. Desperate to restore himself, Hagen turns to Dr. Caitlyn Corr (Naomi Ackie), whose experimental treatment makes matters worse. So Hagen finds himself on a path from Hollywood’s charming leading man to a Gotham City...
Mt. Waterman ski resort near L.A. relisted for $3.3 million after deal falls through
The historic Mt. Waterman Ski Resort, one of Southern California's steepest ski resorts and only an hour from downtown Los Angeles, was relisted for sale on Wednesday at $3,275,000.
I Spent 5 Days In One Of America's Most Overlooked Places, And I Think I Found My New Favorite Place On Earth
If you know, you really know. View Entire Post ›
Baoji Marathon draws 31,000 runners, highlights ancient culture
From race shirts to finisher medals, the 2026 Baoji Marathon in northwest China's Shaanxi Province brings Baoji's history and culture onto the course.
Who is Kim Jae-young, imposing star of K-dramas Make Me Tingle and The Judge from Hell?
Korean actor Kim Jae-young and his signature locks are back on screen in the currently airing romcom Make Me Tingle, where he takes on the daring role of a sex toy entrepreneur. Since his 2013 acting debut, Kim has played a variety of brooding characters that take advantage of the lithe, imposing frame that helped him start in entertainment as a model. However, Kim was not initially aiming for a career in front of the camera. Rather, he harboured an ambition to be a chef and has said in...
43 Packing Tips So You Can Save That Checked Luggage Fee To Spend On Your Actual Trip
That checked bag? Turns out you won't need it after all. View Entire Post ›
Europe’s most underrated Christmas markets revealed
While Europe’s biggest Christmas markets attract millions of visitors every year, many travellers are seeking lesser-known festive destinations. Travel experts at eShores have revealed five underrated Christmas markets worth adding to this year’s winter travel plans based on their festive charm and growing search interest.
JETOUR Brings Its “Travel+” Ecosystem to Life
For JETOUR, travel means more than discovering new places, it also means respecting and protecting the natural world. As its “Travel+” ecosystem continues to grow, JETOUR is bringing travel, off-road exploration and nature conservation together, encouraging travelers to explore responsibly and help protect the places they visit.
A milestone for La Dolce Vita Orient Express, connecting Rome and Istanbul
La Dolce Vita Orient Express has embarked on its first international journey, departing from Rome Ostiense on 22 October for Istanbul. The five-day, four-night itinerary marks a significant milestone for the train, extending its journeys beyond Italy and bringing together two of Europe’s emblematic destinations through an exceptional travel experience.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.